Consumption of two meals per day is associated with increased intrapancreatic fat deposition in patients with type 2 diabetes: a retrospective study.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
09 2022
Historique:
received: 24 04 2022
accepted: 28 08 2022
entrez: 20 9 2022
pubmed: 21 9 2022
medline: 24 9 2022
Statut: ppublish

Résumé

This study aimed to identify the associations between lifestyle factors and intrapancreatic fat deposition in patients with type 2 diabetes. The participants were 185 patients with type 2 diabetes who were hospitalized at Osaka University Hospital between 2008 and 2020 and underwent abdominal CT during hospitalization. Information regarding lifestyle factors, including the number of meals consumed per day, snacking habits, exercise habits, exercise at work, smoking habits, alcohol intake, insomnia, sleep apnea syndrome, and night-shift working, was acquired from self-administered questionnaires or medical records. We measured the mean CT values for the pancreas (P), liver (L), and spleen (S), and the visceral fat area (VFA), and quantified intrapancreatic and liver ectopic fat accumulation as P-S and L-S, respectively. After adjustment for age, sex, hemoglobin A1c, and body mass index (BMI), participants who consumed two meals per day had significantly lower P-S (higher intrapancreatic fat deposition, p=0.02) than those who consumed three meals per day. There were no significant associations between the number of meals consumed and liver ectopic fat accumulation and VFA (p=0.73 and p=0.67, respectively). Patients with diabetes who consumed two meals per day showed greater intrapancreatic fat deposition than those who consumed three meals per day, even after adjustment for BMI. These findings support the current guideline for diabetes treatment that skipping meals should be avoided.

Identifiants

pubmed: 36126992
pii: 10/5/e002926
doi: 10.1136/bmjdrc-2022-002926
pmc: PMC9490586
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Pancreas. 2009 Aug;38(6):672-5
pubmed: 19506531
Pancreas. 2020 Aug;49(7):924-934
pubmed: 32658076
J Clin Med Res. 2020 Jun;12(6):377-388
pubmed: 32587654
Clinics (Sao Paulo). 2019 Oct 28;74:e1337
pubmed: 31664423
Jpn J Radiol. 2016 Oct;34(10):667-676
pubmed: 27581428
Pancreas. 2018 Sep;47(8):e48-e50
pubmed: 29995705
Diabetes Care. 2016 Oct;39(10):1677-83
pubmed: 27422578
World J Gastroenterol. 2009 Apr 21;15(15):1869-75
pubmed: 19370785
Nutrients. 2019 Nov 26;11(12):
pubmed: 31779112
Pancreas. 2011 Nov;40(8):1234-40
pubmed: 21989024
Radiology. 2014 Apr;271(1):104-12
pubmed: 24475851
J Gastroenterol. 2011 Jun;46(6):769-78
pubmed: 21302121
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4453-8
pubmed: 19255424
Hepatology. 2012 Jun;55(6):2005-23
pubmed: 22488764
Metabolism. 2017 Apr;69:1-13
pubmed: 28285638
Am J Gastroenterol. 2019 Mar;114(3):453-463
pubmed: 30353055
J Gastrointest Surg. 2020 Nov;24(11):2560-2569
pubmed: 31749093
J Diabetes Investig. 2020 Jan;11(1):80-87
pubmed: 31240874
J Am Coll Cardiol. 2017 Oct 10;70(15):1833-1842
pubmed: 28982495
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Biochem Biophys Res Commun. 2006 Aug 18;347(1):192-9
pubmed: 16814251
Radiology. 2004 Jan;230(1):276-80
pubmed: 14695401
Int J Endocrinol. 2012;2012:983814
pubmed: 22675355
J Gastroenterol. 2020 Jul;55(7):712-721
pubmed: 32246380
Radiology. 2007 Aug;244(2):479-85
pubmed: 17641368
Nat Rev Gastroenterol Hepatol. 2022 Mar;19(3):153-168
pubmed: 34880411
Public Health Nutr. 2015 Nov;18(16):3013-9
pubmed: 25686619
Nutrients. 2021 May 05;13(5):
pubmed: 34063109
Clin Endocrinol (Oxf). 2015 Nov;83(5):656-62
pubmed: 26201937
J Diabetes Investig. 2020 Jul;11(4):1020-1076
pubmed: 33021749

Auteurs

Akiko Niki (A)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Megu Y Baden (MY)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan mbaden@endmet.med.osaka-u.ac.jp.
Department of Lifestyle Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Sarasa Kato (S)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Kento Mitsushio (K)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Tomomi Horii (T)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Harutoshi Ozawa (H)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Lifestyle Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Chisaki Ishibashi (C)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Shingo Fujita (S)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Takekazu Kimura (T)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Yukari Fujita (Y)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Community Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Ayumi Tokunaga (A)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Takao Nammo (T)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Kenji Fukui (K)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Junji Kozawa (J)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Iichiro Shimomura (I)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH